Orlando Health Cancer Institute - Lake Mary is a clinical research site located in Lake Mary, Florida, United States 32746.
Crixeo Health Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.
Orlando Health Cancer Institute - Lake Mary has participated in 6 clinical trials with 6 currently active.
Therapeutic areas: Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma, FIGO Stage III Ovarian Cancer 2014.
Sponsors: NRG Oncology, SWOG Cancer Research Network, Alliance for Clinical Trials in Oncology.
Trust Score: 71/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Orlando Health Cancer Institute - Lake Mary has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Orlando Health Cancer Institute - Lake Mary has 6 clinical trials on record, with 6 currently active. Their work covers Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma, FIGO Stage III Ovarian Cancer 2014.
Yes — Orlando Health Cancer Institute - Lake Mary holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.